ISHARES IV PLC AUTO ROBTC by ISHARES IV PLC Stock (OTC: IIVPF)

Latest news for ISHARES IV PLC AUTO ROBTC by ISHARES IV PLC (OTC:IIVPF) Stock

ISHARES IV PLC AUTO ROBTC by ISHARES IV PLC

Danimer Scientific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DNMR#NYSE">DNMR</a>) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(8.20) by 97.8 percent. This is a 53.85 percent increase over losses of $(0.39) per share from the same period last year. The company reported quarterly sales of $8.63 million which beat the analyst consensus estimate of $8.58 million by 0.58 percent. This is a 21.17 percent decrease over sales of $10.95 million the same period last year.

Earnings

News

DNMR

Danimer Scientific Q3 EPS $(0.18) Beats $(8.20) Estimate, Sales $8.63M Beat $8.58M Estimate

Buybacks

BlackLine Board Authorized Repurchase Of Up To $200M

XPON

Expion360 Says Recently Added New OEMs And One Distributor; Says New Relationships Are Expected To Add Incremental Revenue For Q4 And Est. $5M For 2025

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Markets

$BTC

LQR House Approves $1M Bitcoin Purchase As Treasury Reserve And Plans To Retain Up To $10M In Crypto Payments From CWSpirits.com, Reflecting Confidence In Digital Assets' Long-Term Potential

Leerink Partners analyst Thomas Smith upgrades Aclaris Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACRS#NASDAQ">ACRS</a>) from Market Perform to Outperform and raises the price target from $2 to $7.

Upgrades

Price Target

Analyst Ratings

ACRS

Leerink Partners Upgrades Aclaris Therapeutics to Outperform, Raises Price Target to $7

MSFT

ServiceNow And Microsoft Expand Alliance To Modernize Front-Office Processes With Copilot And AI Agents, Enhancing Workflow Integration And Self-Service Capabilities Across Microsoft Applications

Benchmark analyst Todd Brooks reiterates Lancaster Colony (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LANC#NASDAQ">LANC</a>) with a Hold.

Reiteration

LANC

Benchmark Reiterates Hold on Lancaster Colony

PRECICE study, financed by the Umberto Veronesi Foundation and the Italian Ministry of Health, is led by multidisciplinary collaborators including breast surgeons, interventional radiologists, and breast imaging and pathology specialists
PRECICE is exclusively using ProSense&#xAE; to treat all 233 Luminal A and B patients &gt;50 years of age with early-stage breast cancer, a wider population of patients than ICE3 &nbsp;
Article published in European Journal of Cancer Prevention describes the PRECICE study and presents the role of cryoablation in the move toward de-escalation of surgical treatment
CAESAREA, Israel, Nov. 19, 2024 /PRNewswire/ -- <a href="https://icecure-medical.com/">IceCure Medical Ltd.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICCM#NASDAQ">ICCM</a>) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced the publication of an <a href="https://journals.lww.com/eurjcancerprev/citation/9900/cryoablation_of_early_breast_cancer__the_challenge.185.aspx">article</a>&nbsp;titled "Cryoablation of early breast cancer: the challenge towards de-escalation of surgical treatment" in the European Journal of Cancer Prevention.
The article, authored by breast surgeons and interventional radiologists including Director of Interventional Radiology at the European Institute of Oncology in Milan, Italy, Franco Orsi, MD, presents a review of recent studies and literature on cryoablation of breast cancer, stating:
"The scientific assumption moving researchers is that cryoablation could represent a precise and safe alternative to the surgery itself for a selected subgroup of women."
The article highlights the Percutaneous Cryoablation of Low-risk Early Breast Cancer (<a href="https://clinicaltrials.gov/study/NCT06300125">PRECICE</a>) study, led by Principal Investigator, Dr. Orsi. PRECICE is an independent prospective observational 233 patient study that has commenced the enrollment of women 50 years of age and older with unifocal, small (up to 15 mm in diameter), clinically node-negative, luminal A and B breast cancer.
The PRECICE study, which will exclusively use ProSense&#xAE; to conduct all procedures, will evaluate the technical effectiveness of cryoablation with a median follow-up of five years (with early primary and secondary outcomes after three years). The procedure failure rate will be evaluated for possible residual tumor by mammography, ultrasound, and nuclear MRI at two months before radiotherapy and six months after radiotherapy. If relapse is suspected, an image-guided breast biopsy will be performed. Additional endpoints including quality of life, psychological impact, and economic outcomes will also be evaluated.

Biotech

Global

General

ICCM

IceCure's ProSense Chosen For Breast Cryoablation Study Led By The European Institute Of Oncology With Sponsorship From The Italian Ministry Of Health

BEAT

HeartBeam Unveils Data At AHA 2024 For Portable Credit Card-Sized ECG Device; Studies Demonstrate Comparable Arrhythmia Detection To Standard ECGs And Highlight Remote Chest Pain Evaluation To Reduce Heart Attack Care Delays

Lennar To Acquire Rausch Coleman Homes, Terms Not Disclosed

Benchmark analyst Mark Palmer reiterates i3 Verticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IIIV#NASDAQ">IIIV</a>) with a Buy and maintains $33 price target.

IIIV

Benchmark Reiterates Buy on i3 Verticals, Maintains $33 Price Target

Macro Economic Events

Econ #s

Economics

USA Housing Starts (MoM) For October -3.1%; -1.9% Prior

USA Housing Starts For October 1.311M Vs 1.340M Est.; 1.353M Prior

Centene's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNC#NYSE">CNC</a>) short percent of float has risen 87.36% since its last report. The company recently reported that it has 14.44 million shares sold short, which is 3.26% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.7 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Centene Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732023024_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Centene has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Centene's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Centene's peer group average for short interest as a percentage of float is 4.59%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

Looking Into Centene's Recent Short Interest

KeyCorp's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KEY#NYSE">KEY</a>) short percent of float has risen 13.64% since its last report. The company recently reported that it has 17.58 million shares sold short, which is 2.25% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.78 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>KeyCorp Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732023019_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for KeyCorp has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing KeyCorp's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, KeyCorp's peer group average for short interest as a percentage of float is 1.55%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Peering Into KeyCorp's Recent Short Interest

Stanley Black &amp; Decker's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SWK#NYSE">SWK</a>) short percent of float has fallen 25.06% since its last report. The company recently reported that it has 3.47 million shares sold short, which is 2.96% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.77 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Stanley Black &amp; Decker Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732023014_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Stanley Black &amp; Decker has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Stanley Black &amp; Decker's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Stanley Black &amp; Decker's peer group average for short interest as a percentage of float is 3.16%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About Stanley Black & Decker?

USA Building Permits For October 1.416M Vs 1.440M Est.; 1.425M Prior

Benchmark analyst Matthew Harrigan reiterates iLearningEngines (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AILE#NASDAQ">AILE</a>) with a Buy and maintains $18 price target.

AILE

Benchmark Reiterates Buy on iLearningEngines, Maintains $18 Price Target

Porch Group, Inc. ("Porch" or "the Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRCH#NASDAQ">PRCH</a>), a homeowners insurance and vertical software platform, today announced Porch Group Media ("PGM"), the data and marketing subsidiary of Porch, has signed an agreement to license non-exclusively its unique Home Factors insights to California-based insurance MGA, Bamboo Ide8 Insurance Services, LLC. ("Bamboo").
This agreement follows the recent announcement of Home Factors' official third-party launch in the market. Porch Group Media has Home Factors for approximately 90% of US homes, providing unique and valuable insights not previously available. For example, identifying that an electric panel needs repair indicates 41% higher claims frequency. These insights have already demonstrated strong performance with Porch's own insurance carrier, Homeowners of America Insurance Company ("HOA"), where it has contributed to its improvement in loss ratio performance.
Home Factors provides value for consumers and carriers. Consumers can get fairer prices based on the actual risk of their property and insurance carriers are expected to achieve more accurate pricing and lower underwriting costs. Tests with HOA and other third-party partners such as Bamboo continue to validate Home Factors' value in underwriting, rate, claims, marketing and overall risk management. Bamboo is among the first to leverage Home Factors insights for a tech-forward and data-driven approach to underwriting, and reduce the cost of manual underwriting.

PRCH

Porch Group Has Signed An Agreement To License Non-Exclusively Its Unique Home Factors Insights To California-based Insurance MGA, Bamboo Ide8 Insurance Services

WIIM

NXTC

NextCure shares are trading higher after the company highlighted data demonstrating that NC605 resulted in enhanced generation of quality bone and better mechanical properties.

iShares Automation & Robotics UCITS ETF USD (Acc)

Comments

ISHARES IV PLC AUTO ROBTC by ISHARES IV PLC

News

Latest news for ISHARES IV PLC AUTO ROBTC by ISHARES IV PLC (OTC:IIVPF) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga